| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/03/2000 | CA2359030A1 Substituted phenethylamine derivatives |
| 08/02/2000 | EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 08/02/2000 | EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules |
| 08/02/2000 | EP0527889B1 Quinolizinone type compounds |
| 08/02/2000 | CN1261894A Polyol-amino-acid compounds having anti-helicobactor pylori activity |
| 08/01/2000 | US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals. |
| 08/01/2000 | US6096864 Tetrapeptide for the treatment of injuries |
| 08/01/2000 | US6096861 Chemical complex; models for the design of ionophores which can introduce metal cations into cells and organelles |
| 08/01/2000 | US6096778 α-ketoamide multicatalytic protease inhibitors |
| 08/01/2000 | US6096713 Administering to patient a linear or cyclized derivative of glutamic acid-tryptophan dipeptide or a low molecular weight oligo- or polypeptide based upon the dipeptide unit |
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
| 08/01/2000 | US6096710 Collagen-like peptoid residue-containing structures |
| 08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 08/01/2000 | CA1341064C Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions |
| 08/01/2000 | CA1341063C Dipeptide crystals, a process for their production, tablets containing the dipeptide crystals and a process for the production |
| 07/27/2000 | WO2000043417A1 Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation |
| 07/27/2000 | WO2000043416A1 N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER SYNERGISTIC SWEETENER BLENDS |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043000A1 Proteasome inhibitors |
| 07/27/2000 | WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 07/27/2000 | WO1999036431A9 Compounds with growth hormone releasing properties |
| 07/27/2000 | CA2359561A1 Proteasome inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359096A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/26/2000 | EP1022268A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/26/2000 | EP1021424A1 Thiadiazole amide mmp inhibitors |
| 07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP1021169A1 Active agent transport systems |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/25/2000 | US6093816 For transfecting nucleic acids, proteins, oligonucleotides or peptides into prokaryotic or eukaryotic cells by forming a complex with polyanions; toxicity to the cells; nontoxic; drug delivery; antitumor-, carcinogenic agents; fungicides |
| 07/25/2000 | US6093813 Cephalosporin compounds |
| 07/25/2000 | US6093797 Modifications of the tripeptide hormone melanocyte stimulating inhibitory factor; can cross blood-brain barrier; side effect reduction |
| 07/25/2000 | US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
| 07/25/2000 | US6093555 Amido and peptido modified enzymatic nucleic acid molecules |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042062A1 Novel depsipeptide compound |
| 07/20/2000 | WO2000042061A1 Method for preparing bicyclic compounds and use of said method for preparing an interleukin-1β conversion enzyme (ice) inhibitor |
| 07/20/2000 | WO2000042060A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | WO2000041685A1 Ccr-3 receptor antagonists |
| 07/20/2000 | WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 07/20/2000 | WO2000018418A3 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/20/2000 | WO2000001687A9 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | CA2353088A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/19/2000 | EP1020431A1 Method of purifying and recovering sweetener |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019533A1 Silanol enzyme inhibitors |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019402A1 Polymorphic forms of a growth hormone secretagogue |
| 07/19/2000 | EP1019370A1 Ace-inhibitor nitric salts |
| 07/19/2000 | EP1019364A2 Inhibitors of protein tyrosine phosphatase |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019070A1 Bradykinin analogs as selective inhibitors of cell activation |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP0772628B1 Peptide derived radionuclide chelators |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/18/2000 | US6090972 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090913 Transesterification and other conversion reactions of acid derivatives, using an amidine base |
| 07/18/2000 | US6090787 Antithrombotic agents |
| 07/18/2000 | US6090785 Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090542 Inhibiting the activity of nf-kb, a transcription factor, by treating the cells with a substance which specifically inhibits the proteolytic degradation of ikb-alpha |
| 07/13/2000 | WO2000040611A1 Slimming cosmetic compositions |
| 07/13/2000 | WO2000040601A1 Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040599A1 Polyol compounds, their production and use |
| 07/13/2000 | WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040564A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | CA2358955A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
| 07/13/2000 | CA2358939A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | CA2356919A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | CA2354531A1 Polyol compounds, their production and use |
| 07/12/2000 | EP1018516A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 07/12/2000 | EP1017711A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 07/12/2000 | EP1017383A1 Thrombin inhibitors |
| 07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0635027B1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087375 Methods of treating or preventing thromboses |